Press Release

<< Back
Printer Friendly Version View printer-friendly version
Depomed to Report Fourth Quarter Fiscal Year 2016 Financial Results on Tuesday, February 21, 2017

NEWARK, Calif., Feb. 17, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release fourth quarter fiscal year 2016 financial results after the close of market, Tuesday, February 21, 2017. The Company will host a conference call beginning at 4:30 p.m. EST (1:30 p.m. PST) to discuss its results.

Participants can access the call by dialing (866) 643-3010 (United States) or (857) 270-6032 (International) referencing Conference ID 71033060. The conference call will also be available via a live webcast on the Investor Relations section of Depomed's website at http://www.depomed.com. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit www.depomed.com.

INVESTOR AND MEDIA CONTACT:

Christopher Keenan

VP, Investor Relations and Corporate Communications

510-744-8000

ckeenan@depomed.com

Primary Logo

Depomed, Inc